Abstract
The purpose of this chapter is to review our knowledge of the effects of nutritional and lifestyle factors on high-density lipoprotein (HDL) metabolism. Alcohol intake increases HDL apolipoprotein (apo) A-I by increasing its production, and is the topic of a chapter by Dr. Brinton. Dietary cholesterol increases HDL apolipoprotein (apo) A-I by increasing its secretion, probably due to a greater need for enhanced reverse cholesterol transport. Diets high in polyunsaturated fatty acids relative to saturated fatty acids and monounsaturated fatty acids (oleic acid), as well as high carbohydrate, low-fat diets, lower HDL apoA-I by enhancing its fractional clearance, due to upregulation of hepatic scavenger receptor B1 (SR-B1) activity. Omega-3 fatty acids have little effect on HDL cholesterol or apoA-I levels, but decrease both apoA-I production as well as its fractional catabolism; but they do increase large beneficial HDL particles. Trans fatty acids lower HDL apoA-I, by modestly enhancing its fractional clearance. Dietary carbohydrate, especially refined carbohydrate high in sugar or high-fructose corn syrup, when replacing fat in the diet, lowers HDL apoA-I by enhancing its fractional clearance. Alterations in dietary protein have little effect on HDL metabolism. Weight loss via caloric restriction and increased exercise decrease TRL levels, resulting in less transfer of cholesteryl ester from HDL to TRL in exchange for triglyceride, and delayed fractional clearance of HDL apoA-I. Weight loss, exercise, and restriction of sugars are the most effective way to raise HDL cholesterol. In intervention studies, replacement of animal fat with vegetable oil and increasing n3 fatty acids in the diet have been associated with significant heart disease risk reduction.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Nicolosi RJ, Stucchi AF, Kowala MC et al (1990) Effect of dietary fat saturation and cholesterol on low density lipoprotein composition and metabolism. I. In vivo studies of receptor and non-receptor mediated catabolism of LDL in Cebus monkeys. Arteriosclerosis 10:119–128
Hennessy LK, Osada J, Ordovas JM et al (1992) Effects of dietary fatty acids and cholesterol on liver lipid content and hepatic apolipoprotein A-I, B and E and LDL receptor mRNA levels in Cebus monkeys. J Lipid Res 33:351–360
Stucchi AF, Hennessy LK, Vespa DB et al (1991) Effect of corn and coconut oil-containing diets with and without cholesterol on high density lipoprotein apoprotein A-I metabolism and hepatic apoprotein A-I mRNA levels in Cebus monkeys. Arterioscler Thromb 11:1719–1729
Lichtenstein AH, Ausman LM, Carrasco W et al (1994) Hyper-cholesterolemic effect of dietary cholesterol in diets enriched in polyunsaturated and saturated fat. Arterioscler Thromb 14:168–175
Velez-Carrasco W, Lichtenstein AH, Welty FK et al (1999) Dietary restriction of saturated fat and cholesterol decreases HDL apoA-I secretion. Arterioscler Thromb Vasc Biol 19:918–924
Schaefer EJ, Levy RI, Ernst ND et al (1981) The effects of low cholesterol, high polyunsaturated fat, and low fat diets on plasma lipid and lipoprotein cholesterol levels in normal and hypercholesterolemic subjects. Am J Clin Nutr 34:1758–1763
Lichtenstein AH, Carrasco W, Jenner JL et al (1993) Effects of canola, corn, olive, and rice bran oil on fasting and post-prandial lipoproteins in humans as part of a National Cholesterol Education Program Step 2 diet. Arterioscler Thromb 13:1533–1542
Brousseau ME, Schaefer EJ, Stucchi AF et al (1995) Diets enriched in unsaturated fatty acids enhance apolipoprotein A-I catabolism but do not affect either its production or hepatic mRNA abundance in cynomolgus monkeys. Atherosclerosis 15:107–119
Brousseau ME, Ordovas J, Osada J et al (1995) Dietary monounsaturated and polyunsaturated fatty acids are comparable in their effects on hepatic apolipoprotein mRNA abundance and liver lipid concentrations when substituted for saturated fatty acids in cynomolgus monkeys. J Nutr 125:425–436
Spady DK, Kearney DM, Hobbs HH (1999) Polyunsaturated fatty acids upregulate hepatic scavenger receptor B1 (SR-B1) expression and HDL cholesteryl ester uptake in the hamster. J Lipid Res 40:1384–1394
Leren P (1966) The effect of plasma cholesterol lowering diet in male survivors of myocardial infarction. Acta Med Scand 466:1–92
Dayton S, Pearce ML, Goldman H et al (1968) Controlled trial of a diet high in unsaturated fat for prevention of atherosclerotic complications. Lancet 2:1060–1062
Turpeinen O (1979) Effect of a cholesterol lowering diet on mortality from coronary heart diseases and other causes. Circulation 59:1–7
Frenais R, Ouguerram K, Maugeais C et al (2001) Effect of dietary omega-3 fatty acids on high density lipoprotein apolipoprotein AI kinetics in type II diabetes mellitus. Atherosclerosis 157:131–135
Chan DC, Watts GF, Barrett PHR (2006) Factorial study of the effect of n-3 fatty acid supplementation and atorvastatin on the kinetics of HDL apolipoproteins A-I and A-II in men with abdominal obesity. Am J Clin Nutr 84:37–43
Schaefer EJ, Lichtenstein AH, Lamon-Fava S et al (1995) Efficacy of a National Cholesterol Education Program Step 2 Diet in normolipidemic and hyperlipidemic middle aged and elderly men and women. Arterioscler Thromb Vasc Biol 15:1079–1085
Schaefer EJ, Lichtenstein AH, Lamon-Fava S et al (1996) Effects of National Cholesterol Education Program Step 2 diets relatively high or relatively low in fish-derived fatty acids on plasma lipoproteins in middle-aged and elderly subjects. Am J Clin Nutr 63:234–241
Schaefer EJ, Lamon-Fava S, Ausman LM et al (1997) Individual variability in lipoprotein cholesterol response to National Cholesterol Education Program Step 2 diets. Am J Clin Nutr 65:823–830
Schaefer EJ, Lichtenstein AH, Lamon-Fava S et al (1995) Body weight and low-density lipoprotein cholesterol changes after consumption of a low fat ad libitum diet. JAMA 274:1450–1455
Dansinger ML, Gleason JA, Griffith JL et al (2005) Comparison of the Atkins, Ornish, Weight Watchers, and Zone diets for weight loss and heart disease risk reduction. JAMA 293:43–53
Blum CB, Levy RI, Eisenberg S et al (1977) High density lipoprotein metabolism in man. J Clin Invest 60:795–807
Brinton EA, Eisenberg S, Breslow JL (1990) A low-fat diet decreases high density lipoprotein (HDL) cholesterol by decreasing HDL apolipoprotein transport rates. J Clin Invest 85:144–151
Schaefer EJ, Gleason JA, Dansinger ML (2009) Dietary fructose and glucose differentially affect lipid and glucose homeostasis. J Nutr 139(6):1257S-1262S
Stanhope Kl, Schwartz JM, Keim NL et al (2009) Consuming fructose sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids, and decreases insulin sensitivity in overweight and obese subjects. J Clin Invest 119:1322–1334
Woollett LA, Spady DK (1997) Kinetic parameters for high density lipoprotein apoprotein AI and cholesteryl ester transport in the hamster. J Clin Invest 99:1704–1713
Woollett LA, Kearney DM, Spady DK (1997) Diet modification alters HDL cholesterol, but not the transport of HDL cholesteryl ester to the liver in the hamster. J Lipid Res 38:2289–2302
Asztalos BF, Lefevre M, Wong L et al (2000) Differential response to low fat diet between low and normal HDL cholesterol subjects. J Lipid Res 41:321–328
Dattilo AM, Kris-Etherton PM (1992) Effects of weight reduction on blood lipids and lipoproteins: a meta analysis. Am J Clin Nutr 56:320–328
Schaefer EJ, Lamon-Fava S, Ordovas JM et al (1994) Factors associated with low and elevated plasma high density lipoprotein cholesterol and apolipoprotein A-1 levels in the Framingham Offspring Study. J Lipid Res 35:871–882
Lamon-Fava S, Wilson PWF, Schaefer EJ (1996) Impact of body mass index on coronary heart risk factors in men and women. The Framingham Offspring Study. Arterioscler Thromb Vasc Biol 16:1509–1515
Rubins HB, Robins SJ, Collins D et al. For the VA-HIT Study Group (2002) Diabetes, plasma insulin, and cardiovascular disease. Subgroup Analysis From the Department of Veterans Affairs High-Density Lipoprotein Intervention Trial (VA-HIT). Arch Intern Med 162:2597–2604
Asztalos BF, Swarbrick MM, Schaefer EJ et al (2009) Effects of weight loss, induced by gastric bypass surgery, on HDL remodeling in obese women. J Lipid Res in press 2010
Lipson LC, Bonow RO, Schaefer EJ et al (1980) Effect of exercise conditioning on plasma high density lipoproteins (HDL) and other lipoproteins. Atherosclerosis 37:529–538
Lamon-Fava S, McNamara JR, Farber HW et al (1989) Acute changes in lipid, lipoproteins, apolipoproteins and low density lipoprotein particle size after an endurance triathlon. Metabolism 38:921–925
Thompson PD, Jurqalevitch SM, Flynn MM et al (1997) Effects of prolonged exercise training without weight loss on HDL metabolism in overweight men. Metabolism 46:217–223
Steffen-Battey L, Nichaman MZ, Goff DC Jr et al (2000) Change in physical activity and risk of all cause mortality: the Corpus Christi Heart Project. Circulation 102:2204–2209
Mensink RP, Katan MB (1992) Effect of dietary fatty acids on serum lipids and lipoproteins: a meta analysis of 27 trials. Arterioscler Thromb 12:911–919
Kris-Etherton PM, Yu S (1995) Individual fatty acid effects on plasma lipids and lipoproteins: human studies. Am J Clin Nutr 65(Suppl):1628S-1644S
Schaefer EJ (2002) E.V. McCollum Award Lecture: Lipoproteins, nutrition, and heart disease. Am J Clin Nutr 75:191–212
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Schaefer, E.J. (2010). Nutritional and Lifestyle Factors and High-Density Lipoprotein Metabolism. In: Schaefer, E. (eds) High Density Lipoproteins, Dyslipidemia, and Coronary Heart Disease. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-1059-2_15
Download citation
DOI: https://doi.org/10.1007/978-1-4419-1059-2_15
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4419-1058-5
Online ISBN: 978-1-4419-1059-2
eBook Packages: MedicineMedicine (R0)